These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 77305)

  • 1. Effect of colchicine on the antibody response. I. Enhancement of antibody formation in mice.
    Shek PN; Coons AH
    J Exp Med; 1978 Apr; 147(4):1213-27. PubMed ID: 77305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of colchicine on the antibody response. II. Demonstration of the inactivation of suppressor cell activities by colchicine.
    Shek PN; Waltenbaugh C; Coons AH
    J Exp Med; 1978 Apr; 147(4):1228-35. PubMed ID: 306409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of trinitrophenyl-specific humoral response to TNP proteins as the result of carrier chlorination.
    Marcinkiewicz J; Olszowska E; Olszowski S; Zgliczynski JM
    Immunology; 1992 Jul; 76(3):385-8. PubMed ID: 1382040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunosuppressive properties of vinblastine and colchicine].
    Leont'eva TI; Maksimova GF; Babichev VA; Uteshev BS
    Tsitologiia; 1977 Feb; 19(2):186-91. PubMed ID: 18824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the control of antibody synthesis. XVII. Effect of specific suppressor cells on the affinity of the antibody response by naive or primed lymphocytes.
    Dekruyff RH; Furie RA; Siskind GW
    Immunology; 1980 Jun; 40(2):255-64. PubMed ID: 6157641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of auto-anti-idiotypic antibody during the normal immune response to TNP-Ficoll. II. Hapten-reversible inhibition of anti-TNP plaque-forming cells by immune serum as an assay for auto-anti-idiotypic antibody.
    Goidl EA; Schrater AF; Siskind GW; Thorbecke GJ
    J Exp Med; 1979 Jul; 150(1):154-65. PubMed ID: 312904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigen structural requirements for immunoglobulin isotype switching in mice.
    Chen P; Nitecki DE; Lewis GK; Goodman JW
    J Exp Med; 1980 Dec; 152(6):1670-83. PubMed ID: 6161201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune responses in vitro. 3. Development of primary gamma-M, gamma-G, and gamma-A plaque-forming cell responses in mouse spleen cell cultures stimulated with heterologous erythrocytes.
    Pierce CW; Johnson BM; Gershon HE; Asofsky R
    J Exp Med; 1971 Aug; 134(2):395-416. PubMed ID: 4934502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oscillations of IgM antibody affinity at the level of single immunocytes.
    Pini C; Di Felice G; Neri R; Mancini C; Vicari G; Doria G
    J Immunol; 1980 Sep; 125(3):1349-54. PubMed ID: 6157726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of anti-hapten (TNP) antibody response by suppressor T cells and their product. The role of macrophages.
    Mizerski J; Noworolski J; Zembala M
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):411-5. PubMed ID: 312076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody formation in the mouse induced by hapten-carrier complexes.
    Snippe H; Graven WG; Willems PJ
    Immunology; 1975 May; 28(5):885-95. PubMed ID: 48501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of the immune system by synthetic polynucleotides. V. Effect on cell-associated immunoglobulin receptors and immunological memory.
    Stout RD; Johnson AG
    J Exp Med; 1972 Jan; 135(1):45-67. PubMed ID: 4109807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of colchicine on the population of antibody producing cells in the secondary immunologic response].
    Pershin SN; Pinegin BV; Uteshev BS
    Zh Mikrobiol Epidemiol Immunobiol; 1971 Jan; 48(1):129-32. PubMed ID: 5102821
    [No Abstract]   [Full Text] [Related]  

  • 14. Early expression in (NZB X DBA/2)F1 hybrids of thymus dysfunction and abnormal antibody production inherited from the NZB parent.
    Quere P; Savino W; Dardenne M; Bach MA
    Eur J Immunol; 1985 Feb; 15(2):112-7. PubMed ID: 3871696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of auto-anti-idiotypic antibody during the normal immune response to TNP-ficoll. I. Occurrence in AKR/J and BALB/c mice of hapten-augmentable, anti-TNP plaque-forming cells and their accelerated appearance in recipients of immune spleen cells.
    Schrater AF; Goidl EA; Thorbecke GJ; Siskind GW
    J Exp Med; 1979 Jul; 150(1):138-53. PubMed ID: 312903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effector cell blockade. A new mechanism of immune hyporeactivity induced by multivalent antigens.
    Schrader JW; Nossal GJ
    J Exp Med; 1974 Jun; 139(6):1582-98. PubMed ID: 4133616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of a pokeweed mitogen-stimulated plaque-forming cell response by a human B lymphocyte-derived aggregated IgG-stimulated suppressor factor: suppressive B cell factor (SBF).
    Pisko EJ; Foster SL; White RE; Panetti M; Turner RA
    J Immunol; 1986 Mar; 136(6):2141-50. PubMed ID: 2419423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific susceptibility of sensitized (memory) B cells to suppression and antigenic alteration by murine leukemia virus.
    Cerny J; Waner EB
    J Immunol; 1975 Feb; 114(2 Pt 1):571-80. PubMed ID: 164504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune suppression in vivo with antigen-modified syngeneic cells. II. T cell-mediated nonresponsiveness to fowl gamma-globulin.
    Sherr DH; Cheung NK; Heghinian KM; Benacerraf B; Dorf ME
    J Immunol; 1979 May; 122(5):1899-904. PubMed ID: 87447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bispecific cells among IgM and IgG producers during the early phase of primary and secondary responses.
    Couderc J; Birrien JL; Oriol R; Bleux C; Liacopoulos P
    Eur J Immunol; 1975 Feb; 5(2):140-7. PubMed ID: 1241945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.